
Home » Prescription Drugs 12 » Olmecip H Benicar H
Olmesartan (ol-ma-SAR-tan) and hydrochlorothiazide (hye-droe-klor-oh-THYE-a-zide) is a combination medicine that belongs to the class of medicines called high blood pressure medicines (antihypertensives). It is used to treat high blood pressure (hypertension). Olmecip controls high blood pressure. It works by blocking the effect of a hormone called angiotensin II. Unopposed this substance prompts the blood vessels to contract an action that tends to raise blood pressure. Olmecip relaxes and expands the blood vessels allowing pressure to drop. Olmecip may be prescribed alone or with other blood pressure medications such as diuretics that help the body get rid of excess water. Olmecip HCT provides just such a combination. It contains Olmecip plus hydrochlorothiazide a common diuretic that increases the output of urine. This removes excess fluid from the body and helps lower blood pressure.
Buy Olmecip H Benicar H and other Prescription Drugs 12 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Olmecip H Benicar H:
Product Type: Prescription Drugs 12
Olmecip-H ( Benicar H Generic Olmesartan & Hydrochlorothiazide )
Olmecip-H (Benicar H Generic Olmesartan & Hydrochlorothiazide)
Benicar H Generic Olmesartan & Hydrochlorothiazide
20/12.5mg
Benicar H Generic Olmesartan & Hydrochlorothiazide Olmecip-H

View more
Prescription Drugs 12
Previous Product Next Product
Without A Prescription:
Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests.
The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections.
Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed.
But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.


|